Delcath Systems, Inc. (NASDAQ- DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product---Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)---is design...
Use this information to figure out if this company is an ideal customer for you.
+1 212-489-2100
1633 Broadway
New York, 10019
Delcath Systems's CEO is Gerard Michel
Delcath Systems's HQ is located at 1633 Broadway, New York
Delcath Systems's phone number is +1 212-489-2100
Delcath Systems's official website is delcath.com
Delcath Systems's revenue is $1M - $5M
Delcath Systems has 51 - 200 employees
Delcath Systems is in the industry of: Pharmaceuticals